These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21463667)

  • 1. Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment.
    Dev RK; Bali V; Pathak K
    Int J Pharm; 2011 Jun; 411(1-2):142-51. PubMed ID: 21463667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon specific CODES based Piroxicam tablet for colon targeting: statistical optimization, in vivo roentgenography and stability assessment.
    Singh AK; Pathak K
    Pharm Dev Technol; 2015 Mar; 20(2):237-45. PubMed ID: 24266719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.
    Paharia A; Yadav AK; Rai G; Jain SK; Pancholi SS; Agrawal GP
    AAPS PharmSciTech; 2007 Feb; 8(1):12. PubMed ID: 17408212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
    Kumar RV; Sinha VR
    Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
    Wu B; Shun N; Wei X; Wu W
    Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach.
    Kulthe SS; Bahekar JK; Godhani CC; Choudhari YM; Inamdar NN; Mourya VK
    Drug Dev Ind Pharm; 2013 Jan; 39(1):138-45. PubMed ID: 22369145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of calcium pectinate beads for target specific drug release to colon.
    Jain A; Gupta Y; Jain SK
    J Drug Target; 2007 May; 15(4):285-94. PubMed ID: 17487697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-fluorouracil loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro release.
    Kaushik D; Sardana S; Mishra DN
    Yao Xue Xue Bao; 2009 Nov; 44(11):1278-84. PubMed ID: 21351727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment.
    Bose A; Elyagoby A; Wong TW
    Int J Pharm; 2014 Jul; 468(1-2):178-86. PubMed ID: 24709212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compression coated systems for colonic delivery of 5-fluorouracil.
    Sinha VR; Singh A; Singh S; Bhinge JR
    J Pharm Pharmacol; 2007 Mar; 59(3):359-65. PubMed ID: 17331338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Assam Bora rice starch as a compression coat of 5-fluorouracil core tablet for colorectal cancer.
    Ahmad MZ; Akhter S; Anwar M; Singh A; Ahmad I; Ain MR; Jain GK; Khar RK; Ahmad FJ
    Curr Drug Deliv; 2012 Jan; 9(1):105-10. PubMed ID: 22023205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats.
    He W; Du Q; Cao DY; Xiang B; Fan LF
    Int J Pharm; 2008 Feb; 348(1-2):35-45. PubMed ID: 17697758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS
    Eur J Pharm Sci; 2002 Aug; 16(3):185-92. PubMed ID: 12128173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.
    Talukder RM; Fassihi R
    J Pharm Pharmacol; 2008 Oct; 60(10):1297-303. PubMed ID: 18812022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet.
    Srivastava R; Kumar D; Pathak K
    Int J Pharm; 2012 May; 427(2):153-62. PubMed ID: 22306039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
    Eur J Pharm Sci; 2003 Aug; 19(5):355-62. PubMed ID: 12907286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
    Shah N; Sharma OP; Mehta T; Amin A
    Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.
    Rai G; Yadav AK; Jain NK; Agrawal GP
    Drug Deliv; 2016; 23(1):328-37. PubMed ID: 24845476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovation of novel 'Tab in Tab' system for release modulation of milnacipran HCl: optimization, formulation and in vitro investigations.
    Parejiya PB; Barot BS; Patel HK; Shelat PK; Shukla A
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1851-63. PubMed ID: 23210688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.